111 related articles for article (PubMed ID: 2703390)
21. Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combination.
Workman P
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1011-4. PubMed ID: 2522916
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
Dische S
Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
[TBL] [Abstract][Full Text] [Related]
23. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
24. Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin.
Inoue S; Hasegawa K; Ito S; Wakamatsu K; Fujita K
Pigment Cell Res; 1993 Oct; 6(5):354-8. PubMed ID: 8302774
[TBL] [Abstract][Full Text] [Related]
25. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
Kagiya VT; Nishimoto S; Ito T; Wang J; Abe M; Sasai K
Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699
[TBL] [Abstract][Full Text] [Related]
26. Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508).
Maughan TS; Newman HF; Bleehen NM; Ward R; Workman P
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1151-6. PubMed ID: 2140825
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.
Verrijk R; Smolders IJ; Huiskamp R; Gavin PR; Philipp KH; Begg AC
Br J Cancer; 1994 Apr; 69(4):641-7. PubMed ID: 8142252
[TBL] [Abstract][Full Text] [Related]
28. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
[TBL] [Abstract][Full Text] [Related]
29. Blue light inhibits melanin synthesis in B16 melanoma 4A5 cells and skin pigmentation induced by ultraviolet B in guinea-pigs.
Ohara M; Kobayashi M; Fujiwara H; Kitajima S; Mitsuoka C; Watanabe H
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):86-92. PubMed ID: 15030593
[TBL] [Abstract][Full Text] [Related]
30. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
Rofstad EK; Brustad T
Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
[TBL] [Abstract][Full Text] [Related]
31. The influence of rutin on the weight, metastasis and melanin content of B16 melanotic melanoma in C57BL/6 mice.
Drewa G; Schachtschabel DO; Pałgan K; Grzanka A; Sujkowska R
Neoplasma; 1998; 45(4):266-71. PubMed ID: 9890672
[TBL] [Abstract][Full Text] [Related]
32. Immunologic enhancement of B16 melanoma growth.
Ershler WB; Tuck D; Moore AL; Klopp RG; Kramer KE
Cancer; 1988 May; 61(9):1792-7. PubMed ID: 3258540
[TBL] [Abstract][Full Text] [Related]
33. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
[TBL] [Abstract][Full Text] [Related]
34. Si(IV)-methoxyethylene-glycol-naphthalocyanine: synthesis and pharmacokinetic and photosensitizing properties in different tumour models.
Mantareva V; Shopova M; Spassova G; Wöhrle D; Muller S; Jori G; Ricchelli F
J Photochem Photobiol B; 1997 Oct; 40(3):258-62. PubMed ID: 9372614
[TBL] [Abstract][Full Text] [Related]
35. In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration.
Williams MV; Denekamp J; Minchinton AI; Stratford MR
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):477-81. PubMed ID: 7107370
[TBL] [Abstract][Full Text] [Related]
36. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
Tada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
[TBL] [Abstract][Full Text] [Related]
37. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
[TBL] [Abstract][Full Text] [Related]
38. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
Chehade F; De Labriolle-Vaylet C; Michelot J; Moins N; Moreau MF; Hindié E; Papon J; Escaig F; Galle P; Veyre A
Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):529-34. PubMed ID: 11441960
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Taghian A; Lespinasse F; Guichard ME
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
[TBL] [Abstract][Full Text] [Related]
40. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Ward R; Workman P; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]